secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0000950170-23-038648
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Laboratories (HSCS) gets Nasdaq bid price deficiency notice; has 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified HSCS on Aug 2, 2023 that common stock bid price was below $1.00 for 30 consecutive business days.
- No immediate impact on listing; company has 180 calendar days to regain compliance (close at $1.00+ for 10 straight days).
- If not cured, HSCS may qualify for an extra 180-day period by meeting other initial listing standards and intending a reverse split.
- Failure to cure could lead to delisting; company is evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023038648/0000950170-23-038648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023038648/hscs-20230802.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-038648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer